Status:
COMPLETED
Drug Use-Results Survey of Betanis Tablets in Japan
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Overactive Bladder
Eligibility:
All Genders
Brief Summary
This study is to determine the following information. 1. The occurrence of adverse drug reactions in clinical settings. 2. Factors potentially impacting safety, effectiveness, and other aspects.
Detailed Description
This survey aims to determine the following information and the need for conducting specified drug use-results surveys and post-marketing clinical studies in patients using Betanis (generic name: mira...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who received mirabegron for the first time for the treatment of urinary urgency, daytime frequency, and urgency incontinence associated with overactive bladder.
Exclusion
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
10711 Patients enrolled
Trial Details
Trial ID
NCT01919047
Start Date
April 1 2012
End Date
July 1 2014
Last Update
October 5 2015
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku, Japan
2
Chūbu, Japan
3
Hokkaido, Japan
4
Kansai, Japan